Clinical Trial

Protocolised Management of Phosphate Replacement Trial

Study acronym: PROMPT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this cluster, crossover, randomised controlled trial is to compare two standard arms of treatment for the replacement of phosphate in critically ill patients. We hypothesise that protocolised restricted phosphate replacement, compared to protocolised liberal phosphate replacement, will result in reduced administration of phosphate with similar clinical outcomes. All eligible Intensive Care Unit (ICU) patients will be included during their admission with the selected protocol for that period as per usual practice and treatment standards.
Trial Details
NCT Number NCT07288944
Lead Sponsor Caboolture Hospital
Collaborators: Queensland University of Technology
Conditions Phosphate Deficiency, Hypophosphatemia, Protocol Optimization, Critical Care, Intensive Care
Enrollment 2,400 participants
Start Date 2026-01
Primary Completion 2027-02 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-17